ADMA Biologics (ADMA)
Manufactures plasma-derived immune globulins for primary immune deficiency and hepatitis B exposure.
$9.51
vs last close−0.30 (−3.06%)
Something off on this page? Send us feedback.
Next report
Nov 4, 26
in 42 days
EPS estimate
$0.19
Revenue estimate
$138.1M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$0.14$0.14$0.15$0.16$0.20$0.19$0.16Pending
Estimate$0.15$0.16$0.14$0.16$0.19$0.19$0.16$0.19
Surprise−6.7%−12.5%+7.1%0.0%+8.1%−1.7%−2.0%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Feb '26May '26Aug '26Nov '26
Reported$117.5M$114.8M$122.0M$134.2M$139.2M$114.5M$124.4MPending
Estimate$108.7M$121.8M$130.3M$139.8M$139.6M$140.0M$125.3M$138.1M
Surprise+8.2%−5.7%−6.4%−4.0%−0.3%−18.2%−0.8%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | $0.23 | — | — |
| Sep 2027 | $0.21 | — | — |
| Jun 2027 | $0.20 | — | — |
| Mar 2027 | $0.17 | — | — |
| Dec 2026 | $0.24 | — | — |
| Nov 2026 | $0.19 | — | — |
| Aug 2026 | $0.16 | $0.16 | −2.0% |
| May 2026 | $0.19 | $0.19 | −1.7% |
| Feb 2026 | $0.19 | $0.20 | +8.1% |
| Nov 2025 | $0.16 | $0.16 | 0.0% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Mar 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Mar 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Mar 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Mar 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Nov 2016 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | $0.23 | — | — | $162.5M | — | — | — |
| Sep 2027 | $0.21 | — | — | $152.1M | — | — | — |
| Jun 2027 | $0.20 | — | — | $145.5M | — | — | — |
| Mar 2027 | $0.17 | — | — | $139.8M | — | — | — |
| Dec 2026 | $0.24 | — | — | $158.4M | — | — | — |
| Nov 4, 2026 | $0.19 | — | — | $138.1M | — | — | — |
| Aug 5, 2026 | $0.16 | $0.16 | −2.0% | $125.3M | $124.4M | −0.8% | +8.6% |
| May 6, 2026 | $0.19 | $0.19 | −1.7% | $140.0M | $114.5M | −18.2% | −16.0% |
| Feb 25, 2026 | $0.19 | $0.20 | +8.1% | $139.6M | $139.2M | −0.3% | −3.2% |
| Nov 5, 2025 | $0.16 | $0.16 | 0.0% | $139.8M | $134.2M | −4.0% | −8.7% |
| Aug 6, 2025 | |||||||
| May 7, 2025 | |||||||
| Mar 3, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 9, 2024 | |||||||
| Feb 28, 2024 | |||||||
| Nov 8, 2023 | |||||||
| Aug 9, 2023 | |||||||
| May 10, 2023 | |||||||
| Mar 23, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 10, 2022 | |||||||
| May 11, 2022 | |||||||
| Mar 24, 2022 | |||||||
| Nov 10, 2021 | |||||||
| Aug 11, 2021 | |||||||
| May 12, 2021 | |||||||
| Mar 25, 2021 | |||||||
| Nov 5, 2020 | |||||||
| Aug 5, 2020 | |||||||
| May 6, 2020 | |||||||
| Mar 12, 2020 | |||||||
| Nov 6, 2019 | |||||||
| Aug 8, 2019 | |||||||
| May 8, 2019 | |||||||
| Mar 13, 2019 | |||||||
| Nov 8, 2018 | |||||||
| Aug 10, 2018 | |||||||
| May 14, 2018 | |||||||
| Mar 5, 2018 | |||||||
| Nov 3, 2017 | |||||||
| Aug 11, 2017 | |||||||
| May 12, 2017 | |||||||
| Feb 24, 2017 | |||||||
| Nov 10, 2016 | |||||||
| Aug 12, 2016 | |||||||
| May 13, 2016 | |||||||
| Mar 23, 2016 | |||||||
| Nov 10, 2015 | |||||||
| Aug 11, 2015 |